{"id":"W2564144331","doi":"10.1161/circ.120.suppl_18.s1002","title":"Abstract 4762: Cessation of Rivaroxaban in Post-ACS Patients is Not Associated With Clinical Evidence of Rebound Hypercoagulability: An ATLAS ACS-TIMI 46 Substudy","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Gibson Energy (Canada)","funders":"","keywords":"Rivaroxaban; Medicine; Discontinuation; Placebo; TIMI; Internal medicine; Stroke (engine); Hazard ratio; Clinical endpoint; Population; Myocardial infarction; Randomized controlled trial; Warfarin; Atrial fibrillation; Thrombolysis; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002784851,0.0005932632,0.001730697,0.00055188,0.0004423664,0.001068368,0.0004120757,0.001134446,0.003354054],"category_scores_gemma":[0.002203114,0.0003286745,0.002002535,0.001354849,0.0003855904,0.0005066666,0.0003627247,0.0009038041,0.0006412535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003863478,"about_ca_system_score_gemma":0.0005505132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001762573,"about_ca_topic_score_gemma":0.003675266,"domain_scores_codex":[0.9983943,0.0008622366,0.0001947569,0.000156201,0.0002675847,0.0001249702],"domain_scores_gemma":[0.9981502,0.0004482381,0.0006916001,0.0002266156,0.0002515627,0.0002318472],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.394304,0.00288095,0.4707176,0.006698478,0.0330979,0.0006296984,0.0003239433,0.0006357336,0.005462917,0.0003194195,0.01839962,0.06652968],"study_design_scores_gemma":[0.05477222,0.01897304,0.8953221,0.0005166018,0.01776768,0.0006917305,0.00008843107,0.0005540061,0.0009635721,0.0002132705,0.01007312,0.00006420534],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9492671,0.03280327,0.0003831808,0.0006705953,0.0003240264,0.000795635,0.01092705,0.00004184096,0.004787239],"genre_scores_gemma":[0.9808803,0.006192792,0.0002604663,0.0009606059,0.001092984,0.0008149071,0.008721899,0.00001161363,0.001064539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003354054,"threshold_uncertainty_score":0.01472789,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1475151754935347,"score_gpt":0.3927741540074012,"score_spread":0.2452589785138664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}